Only four of 66 undesirable outcomes attributed to statins were significant, according to a new study in the Lancet.

A federal judge late Tuesday refused to issue an order that would have blocked several companies from selling generic versions of the Crestor cholesterol pill in the US. The decision is a blow to ...

CRESTOR is not approved to prevent cardiovascular morbidity and mortality. CRESTOR is contraindicated in patients with a known hypersensitivity to any component of this product, in patients with ...

Details suggest two separate medications may present health risks.

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. With the government's blessing, a drug giant is about to expand the market for its blockbuster cholesterol medication Crestor to ...

Pfizer Inc's Lipitor and AstraZeneca's Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients, according to data from a clinical trial ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A Food and Drug Administration advisory panel recommended today that ...

AstraZeneca scored a 'yes' vote at yesterday's FDA advisory panel meeting. The agency's expert advisors recommended the company's cholesterol drug Crestor for broader use--much broader use. If the ...

MUNICH, Aug 31 (Reuters) - AstraZeneca Plc's cholesterol drug Crestor has failed in a second clinical trial for heart failure, suggesting such statin medicines don't improve survival in patients with ...

The new cholesterol-lowering drug Crestor has more potentially harmful side effects than similar drugs and should be taken off the market, according to a lengthy correspondence published in today's ...

The cholesterol drug Crestor is being relabeled to add a caution that starter doses should be reduced in Asian-Americans and some other patients. The Food and Drug Administration said Wednesday that ...

SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- A new analysis from the JUPITER study presented today at the International Stroke Conference (ISC) in San Diego ...